Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

300 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Cerebrospinal fluid NPTX2 changes and relationship with regional brain metabolism metrics across mild cognitive impairment due to Alzheimer's disease.
Massa F, Martinuzzo C, Gómez de San José N, Pelagotti V, Kreshpa W, Abu-Rumeileh S, Barba L, Mattioli P, Orso B, Brugnolo A, Girtler N, Vigo T, Arnaldi D, Serrati C, Uccelli A, Morbelli S, Chincarini A, Otto M, Pardini M. Massa F, et al. Among authors: uccelli a. J Neurol. 2024 Apr;271(4):1999-2009. doi: 10.1007/s00415-023-12154-7. Epub 2023 Dec 29. J Neurol. 2024. PMID: 38157030
COVID-19-associated serum and cerebrospinal fluid cytokines in post- versus para-infectious SARS-CoV-2-related Guillain-Barré syndrome.
Massa F, Vigo T, Bellucci M, Giunti D, Emanuela MM, Visigalli D, Capodivento G, Cerne D, Assini A, Boni S, Rizzi D, Narciso E, Grisanti GS, Coco E, Uccelli A, Schenone A, Franciotta D, Benedetti L. Massa F, et al. Among authors: uccelli a. Neurol Sci. 2024 Mar;45(3):849-859. doi: 10.1007/s10072-023-07279-6. Epub 2024 Jan 3. Neurol Sci. 2024. PMID: 38169013
Psychological resilience is protective against cognitive deterioration in motor neuron diseases.
Rosano A, Bicaj M, Cillerai M, Ponzano M, Cabona C, Gemelli C, Caponnetto C, Pardini M, Signori A, Uccelli A, Schenone A, Ferraro PM. Rosano A, et al. Among authors: uccelli a. Amyotroph Lateral Scler Frontotemporal Degener. 2024 Nov;25(7-8):717-725. doi: 10.1080/21678421.2024.2385690. Epub 2024 Aug 13. Amyotroph Lateral Scler Frontotemporal Degener. 2024. PMID: 39138961 Free article.
Clinical and biological underpinnings of longitudinal atrophy pattern progression in Alzheimer's disease.
Ferraro PM, Filippi L, Ponzano M, Signori A, Orso B, Massa F, Arnaldi D, Caneva S, Argenti L, Losa M, Lombardo L, Mattioli P, Costagli M, Gualco L, Pulze M, Plantone D, Brugnolo A, Girtler N, Diociasi A, Garbarino S, Villani F, Sormani MP, Uccelli A, Roccatagliata L, Pardini M; Alzheimer's Disease Neuroimaging Initiative. Ferraro PM, et al. Among authors: uccelli a. J Alzheimers Dis. 2025 Jan;103(1):243-255. doi: 10.1177/13872877241299843. Epub 2024 Nov 25. J Alzheimers Dis. 2025. PMID: 39587787
MEsenchymal StEm cells for Multiple Sclerosis (MESEMS): a randomized, double blind, cross-over phase I/II clinical trial with autologous mesenchymal stem cells for the therapy of multiple sclerosis.
Uccelli A, Laroni A, Brundin L, Clanet M, Fernandez O, Nabavi SM, Muraro PA, Oliveri RS, Radue EW, Sellner J, Soelberg Sorensen P, Sormani MP, Wuerfel JT, Battaglia MA, Freedman MS; MESEMS study group. Uccelli A, et al. Trials. 2019 May 9;20(1):263. doi: 10.1186/s13063-019-3346-z. Trials. 2019. PMID: 31072380 Free PMC article.
The "central vein sign" to differentiate multiple sclerosis from migraine.
Silvestri G, Roccatagliata L, Tazza F, Schiavi S, Coccia A, Bandettini Di Poggio M, Cellerino M, Signori A, Finocchi C, Uccelli A, Inglese M, Lapucci C. Silvestri G, et al. Among authors: uccelli a. Headache. 2025 Jan 20. doi: 10.1111/head.14902. Online ahead of print. Headache. 2025. PMID: 39834045
300 results